CenterBook Partners’s Bristol-Myers Squibb BMY Stock Holding History

CenterBook Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.59M	Sell	41,540 -16,668	-29%	-$1.05M	0.12%	221
2026 Q2	$3.35M	Buy	58,208 +1,868	+3%	+$107K	0.16%	146
2026 Q1	$3.42M	Buy	+56,340	New	+$3.28M	0.18%	147
2024 Q4	–	Sell	-42,507	Closed	-$2.2M	–	480
2024 Q3	$2.2M	Buy	+42,507	New	+$1.99M	0.14%	186
2023 Q3	–	Sell	-7,605	Closed	-$486K	–	423
2023 Q2	$486K	Buy	7,605 +782	+11%	+$52.4K	0.06%	333
2023 Q1	$473K	Buy	+6,823	New	+$481K	0.07%	316

Other funds holding BMY

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

CenterBook Partners's BMY Position: Q3 2026 in Review

CenterBook Partners reduced its Bristol-Myers Squibb (BMY) stake by 29% in Q3 2026, selling an estimated $1.05M and leaving 41,540 shares worth $2.59M. The position accounts for 0.12% of the portfolio, ranked #221.

CenterBook Partners first reported a position in BMY in Q1 2023 and has held it in 6 quarters since. The position peaked at $3.42M in Q1 2026. 1,427 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

CenterBook Partners held 41,540 shares of Bristol-Myers Squibb worth $2.59M as of Q3 2026.
CenterBook Partners sold 16,668 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.05M.
Bristol-Myers Squibb made up 0.12% of CenterBook Partners's portfolio in Q3 2026, its #221 holding.
CenterBook Partners first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 6 quarters since.
CenterBook Partners's Bristol-Myers Squibb position peaked at $3.42M in Q1 2026.
1,427 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.